Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options. Epidermal growth factor receptor (EGFR) has been shown to be over-expressed in TNBC and represents a rational treatment target. METHODS: We examined single agent and combinati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Canonici, Alexandra, Browne, Alacoque L., Ibrahim, Mohamed F. K., Fanning, Kevin P., Roche, Sandra, Conlon, Neil T., O’Neill, Fiona, Meiller, Justine, Cremona, Mattia, Morgan, Clare, Hennessy, Bryan T., Eustace, Alex J., Solca, Flavio, O’Donovan, Norma, Crown, John
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
TNBC in 2019: Promising Signals for the Treatment of a Formidable Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6987485/
https://ncbi.nlm.nih.gov/pubmed/32064003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919897546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados